Lnc-Tim3, upregulated in hepatocellular carcinoma patients, exerts inhibitory effects on the production of IFN-γ and IL-2 while promoting T-cell exhaustion, closely intertwining with anti-tumor immunity [58]. The gene discussed is IFNG; the disease is neoplasm.